ClinicalTrials.Veeva

Menu

CT Diagnoses in Crohn"s Disease Activity

P

Peking University

Status

Completed

Conditions

Crohn's Disease

Study type

Observational

Funder types

Other

Identifiers

NCT04956991
M2018130

Details and patient eligibility

About

The study focused on the clinical value of CT in assessing the activity of Crohn's disease.

Full description

"Crohn's disease is an inflammatory disease with non-specific clinical manifestations. The lesions are more common in the ileocecal area and the end of the ileum, and also can affect the entire digestive tract. In recent years, the domestic incidence of Crohn's disease has been increasing. At present, CT diagnosis still lacks the gold standard and requirescombination of clinical manifestations, endoscopic examination, imaging examination and laboratory examination results. CT has showed advantages of non-invasive inspection, fast imaging speed, high tissue density resolution, and strong patient acceptability. In addition, the examination can clearly show the internal and external tissue structure of the digestive tract, which has been widely used in the diagnosis and activity evaluation of Crohn's disease.

In order to clarify the clinical value of CT in assessing the activity of Crohn's disease, this study mainly used retrospective analysis of the CT manifestations and clinical data of patients with Crohn's disease to explore the clinical value of CT in assessing the activity of patients with Crohn's disease."

Enrollment

35 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Crohn's disease patients with confirmed endoscopic or pathological examination results
  • Complete laboratory data such as CRP, erythrocyte sedimentation rate, etc.

Exclusion criteria

  • Related inspection results are not complete
  • The interval between endoscopic and laboratory examination results exceeds 2 months

Trial design

35 participants in 2 patient groups

CDAI≤220
Description:
According to the Crohn's disease activity index (CDAI) scores, all the patients included in the study were divided into group A (CDAI≤220)
CDAI>220
Description:
According to the Crohn's disease activity index (CDAI) scores, all the patients included in the study were divided into group B (CDAI\>220)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems